Literature DB >> 28881259

Sodium channel blockers in KCNQ2-encephalopathy: Lacosamide as a new treatment option.

Susanne Schubert-Bast1, Peter Hofstetter2, Doris Fischer3, Rolf Schloesser3, Georgia Ramantani4, Matthias Kieslich5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28881259     DOI： 10.1016/j.seizure.2017.08.005

Source DB:  PubMed          Journal:  Seizure        ISSN： 1059-1311            Impact factor:   3.184


× No keyword cloud information.
  3 in total

1.  KCNQ2 Encephalopathy and Effect of Early Treatment on the Clinical Phenotype.

Authors:  Mahesh Kamate; Anuraag N Reddy; Mayank Detroja
Journal:  Ann Indian Acad Neurol       Date:  2022-01-12       Impact factor: 1.714

2.  In Silico Predictions of KCNQ Variant Pathogenicity in Epilepsy.

Authors:  David M Ritter; Paul S Horn; Katherine D Holland
Journal:  Pediatr Neurol       Date:  2021-01-27       Impact factor: 3.372

Review 3.  Capturing seizures in clinical trials of antiseizure medications for KCNQ2-DEE.

Authors:  John J Millichap; Cynthia L Harden; Dennis J Dlugos; Jacqueline A French; Noam N Butterfield; Celene Grayson; Ernesto Aycardi; Simon N Pimstone
Journal:  Epilepsia Open       Date:  2021-01-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.